Unbound MEDLINE

Cardiovascular disease risk profiles among 'healthy' siblings of patients with early-onset cardiovascular disease: application of the new SCORE system. [Eur J Cardiovasc Prev Rehabil] Journal article

 
TitleCardiovascular disease risk profiles among 'healthy' siblings of patients with early-onset cardiovascular disease: application of the new SCORE system.
Author(s)Horan PG, Kamaruddin MS, Moore MJ, McCarty D, Spence MS, McGlinchey PG, Murphy G, Jardine TC, Patterson CC, McKeown PP 
InstitutionaRegional Medical Cardiology Centre, Royal Victoria Hospital, Belfast, Northern Ireland, UK bDepartments of bEpidemiology and Public Health cMedicine, Queenʼs University Belfast, Belfast, Northern Ireland, UK.
SourceEur J Cardiovasc Prev Rehabil 2007 Aug; 14(4):521-525.
AbstractBACKGROUND: Cardiovascular disease (CVD) occurs more frequently in individuals with a family history of premature CVD. Within families the demographics of CVD are poorly described.
DESIGN: We examined the risk estimation based on the Systematic Coronary Risk Evaluation (SCORE) system and the Joint British Guidelines (JBG) for older unaffected siblings of patients with premature CVD (onset </=55 years for men and </=60 years for women).
METHODS: Between August 1999 and November 2003 laboratory and demographic details were collected on probands with early-onset CVD and their older unaffected siblings. Siblings were screened for clinically overt CVD by a standard questionnaire and 12-lead electrocardiogram (ECG).
RESULTS: A total of 790 siblings was identified and full demographic details were available for 645. The following siblings were excluded: 41 with known diabetes mellitus; seven with random plasma glucose of 11.1 mmol/l or greater; and eight with ischaemic ECG. Data were analysed for 589 siblings from 405 families. The mean age was 55.0 years, 43.1% were men and 28.7% were smokers. The mean total serum cholesterol was 5.8 mmol/l and hypertension was present in 49.4%. Using the SCORE system, when projected to age 60 years, 181 men (71.3%) and 67 women (20.0%) would be eligible for risk factor modification. Using JBG with a 10-year risk of 20% or greater, 42 men (16.5%) and four women (1.2%) would be targeted.
CONCLUSIONS: Large numbers of these asymptomatic individuals meet both European and British guidelines for the primary prevention of CVD and should be targeted for risk factor modification. The prevalence of individuals defined as eligible for treatment is much higher when using the SCORE system.
LanguageENG
Pub Type(s)JOURNAL ARTICLE
PubMed ID17667642
  
Advertise on this site.